The consultation on raising the threshold suggests that this change will “ensure that the BIT continues to target those ...

MERGE announces new Chair. MERGE, a Chicago-based integrated technology and marketing services provider, has a new board ...

Sanofi said in October last year that it was planning to spin off its consumer health business into a separate company before ...

Between digital therapeutics, HCP portals, and patient support communications, pharma companies are investing a significant ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

EVERSANA has signed an agreement with Oracle Argus Cloud to add to the features of its pharmacovigilance platform, which ...

In our penultimate video from ESMO 2024, pharmaphorum spoke with Dr Magda Meissner, consultant medical oncologist at the ...

The landscape of medical technology start-ups is undoubtedly poised for significant evolution due to the FDA’s final rule.

At LSX 2024 in Boston last month, editor-in-chief Jonah Comstock spoke with James Graham, CEO and founder of Recce Pharma, an ...

Artificial intelligence (AI) is an increasingly valuable tool in our perpetual quest for the miracles that science regularly ...